Innoveren Scientific Inc. (IVRN)

Market Cap	5.61K -99.9%
Revenue (ttm)	n/a -71.9%
Net Income	-3.26M
EPS	-5.51
Shares Out	8.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	704
Average Volume	15,711
Open	0.0004
Previous Close	0.0004
Day's Range	0.0004 - 0.0007
52-Week Range	0.000001 - 0.0007
Beta	469.92
RSI	35.82
Earnings Date	n/a

About Innoveren Scientific

Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is headquartered in Tampa, Florida.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Michael Yurkowsky
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: IVRN